Descriptions for Grant Writers
Investigators who are writing grants can find below a description of the Experimental Histopathology shared resource and its services for their grant applications. Descriptions of the overall Fred Hutchinson Cancer Center Shared Resources program are available on the main Shared Resources grant information page.
Examples of publications coauthored or made possible by the staff of the Experimental Histopathology shared resource are listed below.
ON THIS PAGE
Citations for CCSG-Support Research
All publications, press releases, or other documents that cite results from CCSG-supported research must include acknowledgement of the grant and maintain compliance with NIH Public Access Policy. All manuscripts accepted for publication must be submitted to PubMed Central and be assigned a PMCID. Additionally, please reference the Research Resource Identifier (RRID). RRIDs are assigned to cores to help researchers cite key resources in the biomedical literature to improve transparency of research methods.
This research was supported by NIH P30 CA015704 of the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, which includes the Experimental Histopathology Shared Resource, RRID:SCR_022612.
Murdock Charitable Trust Statement:
The Experimental Histopathology Shared Resource equipment is supported by a grant from the M.J. Murdock Charitable Trust grant SR-202221337.
Experimental Histopathology Grant Descriptions
Short Grant Description
The Experimental Histopathology shared resource offers histology, special stains, immunohistochemistry, digital imaging, quantitative image analysis and pathology support. The core has extensive experience with human and animal tissue and provides routine services as well as customized protocol development. Immunohistochemistry and in situ hybridization services include optimization, single or multiplex IHC, single or multiplex ISH with chromagen or fluorescent detection. Spatial genomics services for high plex detection of RNA or protein in tissues are also supported through collaboration with the Genomics Resource.
Long Grant Description
The Experimental Histopathology shared resource is a full-service histology lab with extensive experience working with human specimens and animal models. The core is well-equipped for histology support with automated Sakura Tissue-Tek Paraffin Processors, a Tissue-Tek Paraffin Embedding unit, a Sakura hematoxylin and eosin (H&E) stainer, Leica microtomes, a Leica cryostat, Leica BOND RX immunohistochemistry stainers, Nikon microscopes, and Nikon cameras.
Histology services include OCT embedding and sectioning of frozen samples, tissue fixation, paraffin processing and embedding, sectioning and H&E staining.
The core offers a wide spectrum of special stains, including periodic acid-Schiff (PAS), Wright-Giemsa, Movat’s pentachrome, reticulin, silver stains, iron stain, Masson’s trichrome, Alcian blue, picro-sirius red, nuclear fast red, and stains for various bacteria and fungus. Special stain development is also available to support the needs of various studies.
Extensive immunohistochemistry, multiplex immunohistochemistry and in situ hybridization services are available. The core uses automated immunochemistry stainers in order to offer consistency and standardized protocols on large- and small-scale projects. More than 200 single antibody protocols and more than 150 multiplex IHC protocols are available for staining human and animal tissue. The core also offers services in antibody optimization and novel antibody staining protocols.
Pathology review is available for histology and immunohistochemistry analysis. In addition, the staff collaborates with veterinary/comparative and clinical pathologists. The shared resource has a five-headed Nikon microscope with a camera to facilitate the review of samples and capture critical data.
Digital Pathology Laboratory:
Imaging and analysis of multiplex immunofluorescence staining can be performed in the Digital Pathology and Spatial Biology Laboratory, which is home to multiple imaging and slide scanning systems. The Aperio Versa 200 is a 200-slide capacity imaging system for whole slide imaging of brightfield or fluorescent stains with up to four channels. Two Evident VS200 slide scanners offer flexibility for high capacity brightfield imaging or precision fluorescent imaging of up to four fluorescent markers. Two Akoya PhenoImager HT instruments each offer 80-slide capacity with the capability to perform spectral deconvolution and autofluorescence subtraction for up to nine-color images. HALO AI (Indica Lab) or VisioPharm image analysis software is available to create custom algorithms to quantify IHC or ISH staining results on digital images. The core offers training and independent investigator use on HALO or Visiopharm or analysis services by Experimental Histopathology staff are available.
Spatial Biology:
The Experimental Histopathology Core offers high-plex detection of protein or RNA targets with spatial resolution through its Spatial Biology services. Many of these services are supported by collaborations with the Genomics & Bioinformatics Core and the Fred Hutch Innovation Lab.
The suite of services includes technologies from 10X Genomics, Bruker and Lunaphore to detect ultra high plex RNA and/or protein data with spatial resolution. 10X Genomics' offerings include Visium V1 for RNA detection in fresh frozen tissue, Visium with CytAssist for RNA and high-plex protein detection in both FFPE and frozen tissues, and Visium HD or 3’ for RNA in FFPE and fresh frozen tissues, with spatial resolution ranging from multiple to single-cell. Bruker’s GeoMx enables detection of the entire transcriptome or hundreds of proteins in specific regions while the CosMx offers single cell resolution on hundreds to thousands of protein or RNA markers. The Lunaphore COMET is an automated staining and imaging platform, enabling detection of up to 40 unique protein and/or RNA markers on the same tissue section, with flexibility in panel design at a single-cell resolution.
Selected Publications Made Possible by Experimental Histopathology
This is a partial list of publications. For more publications, contact us.
- Damle SR, Carter JA, Goodsell KE, et al. Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity. Cancer Immunol Res. 2026 Feb 3;14(2):205-218. doi: 10.1158/2326-6066.CIR-25-0062. PMID: 41201469; PMCID: PMC12707859
- Rominger MC, O'Brien S, Gupta S, et al. Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer state. Cell Rep. 2025 Oct 28;44(10):116185. doi: 10.1016/j.celrep.2025.116185. Epub 2025 Sep 24. PMID: 41004338; PMCID: PMC12646131.
- Yamamoto N, Dobersch S, Loveless I, et al. HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2025 Feb 17;31(4):733-745. doi: 10.1158/1078-0432.CCR-24-2200. PMID: 39680021; PMCID: PMC11967372.
- Voillet V, Berger TR, McKenna KM, et al. An In Vivo Model of Human Macrophages in Metastatic Melanoma. J Immunol. 2022 Aug 1;209(3):606-620. doi: 10.4049/jimmunol.2101109. Epub 2022 Jul 11. PMID: 35817516; PMCID: PMC9377377.
- Stone D, Long KR, Lopriena MA, et al. CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice. Mol Ther Methods Clin Dev. 2021;20:258-275. doi:10.1016/j.omtm.2020.11.014